亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Comparative study on the antitumor effects of gemcitabine polybutylcyanoacrylate nanoparticles coupled with anti-human MUC1 and CA199 monoclonal antibodies on pancreatic cancer in vitro and in vivo

单克隆抗体 体内 胰腺癌 吉西他滨 细胞凋亡 抗体 流式细胞术 医学 体外 MUC1号 MTT法 药理学 分子生物学 癌症 癌症研究 抗原 免疫学 内科学 化学 生物 生物化学 生物技术
作者
Lin Zhang,Yanhong Hou,William P. Meehan,Haorun Liu,Yujing Wang
出处
期刊:Arab Journal of Gastroenterology [Elsevier BV]
卷期号:23 (4): 263-269 被引量:3
标识
DOI:10.1016/j.ajg.2022.06.005
摘要

This study was designed to compare the antitumor effects of anti-human MUC1 monoclonal antibody with those of anti-human CA199 monoclonal antibody coupled with drug-loaded polybutylcyanoacrylate nanoparticles on human pancreatic cancer cell lines and pancreatic cancer-bearing model animals and to screen more efficient targeting molecules.Gemcitabine-loaded nanospheres were prepared by emulsion polymerization (GEM-PBCA-NP), and then, anti-MUC1 monoclonal antibody was coupled with GEM-PBCA-NP (MUC1-GEM-PBCA-NP), and anti-human CA199 monoclonal antibody was coupled with GEM-PBCA-NP (CA199-GEM-PBCA-NP), using the chemical crosslinking method. The cell-killing rates were detected using MTT assay. The changes in the tumor cell cycle and apoptosis after treatment were detected using flow cytometry. Then, the subcutaneous planting method was adopted to establish an animal model of pancreatic cancer: two nanometer microspheres were injected into the body of nude mice via the tail vein; the tumor suppression effect was detected after treatment; then, the groups were compared.In vitro, the cell-killing rate of each experimental group was significantly different from that of the control group (P < 05). The MUC1-GEM-PBCA-NP group had a significantly higher cell-killing rate than the other groups (P < 05). The apoptosis rate of the MUC1-GEM-PBCA-NP treatment group was significantly higher than that of other groups (P < 05). In vivo, the tumor inhibition rate of the MUC1-GEM-PBCA-NP treatment group was 72.69% ± 4.29%, which was significantly higher than those of other groups (P < 0.05). The tumor inhibition rate of the CA199-GEM-PBCA-NP treatment group was 56.58% ± 5.11%, which was significantly higher than those of other control groups (P < 0.05). At the end of treatment, the average tumor mass of the MUC1-GEM-PBCA-NP treatment group was 433.55 ± 12.49 mg, which was significantly lower than those of other groups (P < 0.05).Compared with CA199-GEM-PBCA-NP, MUC1-GEM-PBCA-NP is more effective in vitro and in vivo. MUC1 could be a target molecule in treating pancreatic cancer.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
我要读博士完成签到 ,获得积分10
3秒前
卡卡东完成签到 ,获得积分10
4秒前
蛙蛙完成签到,获得积分10
7秒前
威武的元冬完成签到,获得积分20
8秒前
勇敢牛牛完成签到 ,获得积分10
14秒前
泉水丁冬2023完成签到 ,获得积分10
14秒前
glanceofwind完成签到 ,获得积分10
15秒前
Owen应助lsm采纳,获得10
16秒前
学者风范完成签到 ,获得积分10
17秒前
20秒前
22秒前
Eden发布了新的文献求助10
24秒前
25秒前
白一航完成签到,获得积分10
27秒前
29秒前
碳酸芙兰完成签到,获得积分10
34秒前
H_C发布了新的文献求助10
34秒前
43秒前
marcelo完成签到,获得积分10
46秒前
所所应助lv采纳,获得10
47秒前
obsidian完成签到,获得积分10
47秒前
51秒前
科研小牛完成签到,获得积分10
52秒前
54秒前
andrele发布了新的文献求助30
1分钟前
Cathy发布了新的文献求助200
1分钟前
1分钟前
奥黛丽赫本完成签到,获得积分10
1分钟前
鹿茸与共完成签到,获得积分10
1分钟前
酷波er应助lv采纳,获得10
1分钟前
1分钟前
鹿茸与共发布了新的文献求助10
1分钟前
enchanted发布了新的文献求助10
1分钟前
1分钟前
Hqing完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
NIUB完成签到,获得积分10
1分钟前
直率芮完成签到 ,获得积分10
1分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990012
求助须知:如何正确求助?哪些是违规求助? 3532077
关于积分的说明 11256227
捐赠科研通 3270933
什么是DOI,文献DOI怎么找? 1805139
邀请新用户注册赠送积分活动 882270
科研通“疑难数据库(出版商)”最低求助积分说明 809228